Guideline for Disinfection and Sterilization of Prion-Contaminated Medical Instruments
暂无分享,去创建一个
[1] W. Rutala,et al. Managing the risk of nosocomial transmission of prion diseases , 2002, Current opinion in infectious diseases.
[2] R. Rohwer. Virus like sensitivity of the scrapie agent to heat inactivation. , 1984, Science.
[3] R. Buckley,et al. CJD and the eye , 2000, Eye.
[4] J. Stephenson. Halting the spread of human prion disease--exceptional measures for an exceptional problem. , 2007, The Journal of hospital infection.
[5] M. Enari,et al. Infectivity of Scrapie Prions Bound to a Stainless Steel Surface , 1999, Molecular medicine.
[6] D. Fleming,et al. Fatal degenerative neurologic illnesses in men who participated in wild game feasts--Wisconsin, 2002. , 2003, MMWR. Morbidity and mortality weekly report.
[7] Gina Pugliese,et al. Safety and Cleaning of Medical Materials and Devices , 2000, Infection Control & Hospital Epidemiology.
[8] W. Rutala,et al. Guideline for disinfection and sterilization in healthcare facilities, 2008 , 2008 .
[9] G. Mcdonnell. Prion Disease Transmission: Can We Apply Standard Precautions to Prevent or Reduce Risks? , 2008, Journal of perioperative practice.
[10] K. Roth,et al. Infectivity of Prion Protein Bound to Stainless Steel Wires: A Model for Testing Decontamination Procedures for Transmissible Spongiform Encephalopathies , 2004, Infection Control & Hospital Epidemiology.
[11] L. Wilkins. Iatrogenic Creutzfeldt-Jakob disease: The waning of an era , 2006, Neurology.
[12] G. Kampf,et al. Surface fixation of dried blood by glutaraldehyde and peracetic acid. , 2004, The Journal of hospital infection.
[13] P. Brown,et al. Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease , 1994, Annals of neurology.
[14] P. Brown,et al. Novel methods for disinfection of prion-contaminated medical devices , 2004, The Lancet.
[15] M. Chamberland,et al. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] S. Block,et al. Disinfection, sterilization, and preservation , 1977 .
[17] C. Gibbs,et al. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. , 1998, The New England journal of medicine.
[18] J. Collinge,et al. Transmission of Scrapie by Steel-surface-bound Prions , 2001, Molecular medicine.
[19] R. Race,et al. Comparative analysis of scrapie agent inactivation methods. , 1993, Journal of virological methods.
[20] D. Kingsbury,et al. Chemical disinfection of Creutzfeldt-Jakob disease virus. , 1982, The New England journal of medicine.
[21] F. Taguchi,et al. Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease. , 1992, The New England journal of medicine.
[22] L. Manuelidis. Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. , 1997, Journal of neurovirology.
[23] D. Taylor. Inactivation of transmissible degenerative encephalopathy agents: A review. , 2000, Veterinary journal.
[24] J. Collinge,et al. An enzyme-detergent method for effective prion decontamination of surgical steel. , 2005, The Journal of general virology.
[25] I. P. Lipscomb,et al. Effect of drying time, ambient temperature and pre-soaks on prion-infected tissue contamination levels on surgical stainless steel: concerns over prolonged transportation of instruments from theatre to central sterile service departments. , 2007, The Journal of hospital infection.
[26] K. Roth,et al. Inactivation of Animal and Human Prions by Hydrogen Peroxide Gas Plasma Sterilization , 2009, Infection Control & Hospital Epidemiology.
[27] E. Hartley. Action of Disinfectants on Experimental Mouse Scrapie , 1967, Nature.
[28] K. Mølbak,et al. Tissue classification for the epidemiological assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease. A proposal on hypothetical risk levels , 2005, BMC public health.
[29] J. Langeveld,et al. Enzymatic degradation of prion protein in brain stem from infected cattle and sheep. , 2003, The Journal of infectious diseases.
[30] Stanley A. Brown,et al. Use of containment pans and lids for autoclaving caustic solutions. , 2003, American journal of infection control.
[31] John Bartlett,et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .
[32] P. Brown,et al. A simple and effective method for inactivating virus infectivity in formalin‐fixed tissue samples from patients with Creutzfeldt‐Jakob disease , 1990, Neurology.
[33] S. Prusiner,et al. Inactivation of Prions by Acidic Sodium Dodecyl Sulfate , 2006, Journal of Virology.
[34] N. Girard,et al. Standards, recommended practices, and guidelines. , 2006, AORN journal.
[35] M. Alfa,et al. A new hydrogen peroxide--based medical-device detergent with germicidal properties: comparison with enzymatic cleaners. , 2001, American journal of infection control.
[36] D. Taylor. Inactivation of prions by physical and chemical means. , 1999, The Journal of hospital infection.
[37] T. Kitamoto,et al. Practical Methods for Chemical Inactivation of Creutzfeldt‐Jakob Disease Pathogen , 1991, Microbiology and immunology.
[38] P. Marsh,et al. Implications for Creutzfeldt-Jakob Disease (CJD) in Dentistry: a Review of Current Knowledge , 2008, Journal of dental research.
[39] C. Masters,et al. Transmissible spongiform encephalopathies , 2004, The Lancet.
[40] W A Rutala,et al. APIC guideline for selection and use of disinfectants. , 1996, American journal of infection control.
[41] M. Mielke,et al. Activity of an alkaline 'cleaner' in the inactivation of the scrapie agent. , 2004, The Journal of hospital infection.
[42] S. Behrman,et al. Subacute spongiform encephalopathy--a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). , 1960, Brain : a journal of neurology.
[43] D. Taylor,et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie , 2005, Archives of Virology.
[44] P. Liberski,et al. Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. , 1990, The Journal of infectious diseases.
[45] R. Somerville,et al. Comparative studies on the thermostability of five strains of transmissible‐spongiform‐encephalopathy agent , 2007, Biotechnology and applied biochemistry.
[46] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[47] Suvankar Pal,et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report , 2006, The Lancet.
[48] Ken Chen,et al. Chronic Wasting Disease of Elk: Transmissibility to Humans Examined by Transgenic Mouse Models , 2005, The Journal of Neuroscience.
[49] David M. Taylor,et al. Proteolytic inactivation of the bovine spongiform encephalopathy agent. , 2004, Biochemical and biophysical research communications.
[50] D. Taylor. Resistance of the ME7 scrapie agent to peracetic acid. , 1991, Veterinary microbiology.
[51] D. Taylor,et al. The response of the 22A strain of scrapie agent to microwave irradiation compared with boiling , 1996, Neuropathology and applied neurobiology.
[52] J Mackenzie,et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.
[53] N. Fishman,et al. Healthcare Infection Control Practices Advisory Committee , 2012 .
[54] A. Valleron,et al. Risk Assessment of Transmission of Sporadic Creutzfeldt-Jakob Disease in Endodontic Practice in Absence of Adequate Prion Inactivation , 2007, PloS one.
[55] Gina Pugliese,et al. Creutzfeldt-Jakob Disease Recommendations for Disinfection and Sterilization , 2001, Infection Control & Hospital Epidemiology.
[56] Probable variant Creutzfeldt-Jakob disease in a U.S. resident--Florida, 2002. , 2002, MMWR. Morbidity and mortality weekly report.
[57] M. Alter,et al. Infectivity of Hepatitis C Virus in Plasma After Drying and Storing at Room Temperature , 2007, Infection Control & Hospital Epidemiology.
[58] Mary J. Ogg,et al. Recommended practices for cleaning and caring for surgical instruments and powered equipment. , 2002, AORN journal.
[59] Mark Head,et al. Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .
[60] C. Masters,et al. Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain. , 2007, The Journal of general virology.
[61] A. Behrman,et al. Occupational exposure to bloodborne pathogens. , 2004, Annals of internal medicine.
[62] P. Brown,et al. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. , 2001, Emerging infectious diseases.
[63] G. J. Raymond,et al. Inactivation of Transmissible Spongiform Encephalopathy (Prion) Agents by Environ LpH , 2004, Journal of Virology.
[64] W. Rutala,et al. How to Assess Risk of Disease Transmission to Patients When There Is a Failure to Follow Recommended Disinfection and Sterilization Guidelines , 2007, Infection Control & Hospital Epidemiology.
[65] G. Mcdonnell,et al. Investigations of a prion infectivity assay to evaluate methods of decontamination. , 2007, Journal of microbiological methods.
[66] Collective Editorial team. Fourth case of transfusion-associated vCJD infection in the United Kingdom. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[67] Mary J. Ogg,et al. Recommended practices for sterilization in the perioperative practice setting. , 2006, AORN journal.
[68] C Vadrot,et al. Quantitative evaluation of prion inactivation comparing steam sterilization and chemical sterilants: proposed method for test standardization. , 2006, The Journal of hospital infection.
[69] J. T. Walker,et al. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard? , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[70] J. Solassol,et al. A novel copper-hydrogen peroxide formulation for prion decontamination. , 2006, The Journal of infectious diseases.
[71] C. Goodman. Association for the Advancement of Medical Instrumentation , 1988 .
[72] M. Yoshioka,et al. Assessment of Prion Inactivation by Combined Use of Bacillus-Derived Protease and SDS , 2007, Bioscience, biotechnology, and biochemistry.
[73] J. M. Ascenzi,et al. A more accurate method for measurement of tuberculocidal activity of disinfectants , 1987, Applied and environmental microbiology.
[74] C. Penet,et al. Decontamination of prion protein (BSE301V) using a genetically engineered protease. , 2009, The Journal of hospital infection.
[75] H. Mizusawa,et al. Ophthalmic Surgery in Prion Diseases , 2007, Emerging infectious diseases.
[76] C. Anderson,et al. Human Prion Disease and Relative Risk Associated with Chronic Wasting Disease , 2006, Emerging infectious diseases.
[77] Persis Mehta,et al. Disinfection of medical and surgical materials. , 1971, American journal of hospital pharmacy.
[78] P. Brown,et al. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. , 1986, The Journal of infectious diseases.
[79] G. Pauli,et al. Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces. , 2004, The Journal of general virology.
[80] A. Simpson,et al. Elimination of transmissible spongiform encephalopathy infectivity and decontamination of surgical instruments by using radio-frequency gas-plasma treatment. , 2005, The Journal of general virology.
[81] R. Rosenberg. Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt‐Jakob disease , 1986, Annals of neurology.
[82] A. Hamad,et al. Iatrogenic Creutzfeldt–Jakob disease at the millennium , 2001, Neurology.
[83] J. Sejvar,et al. Variant Creutzfeldt-Jakob Disease Death, United States , 2005, Emerging infectious diseases.
[84] D. Taylor,et al. Disinfection studies with two strains of mouse-passaged scrapie agent Guidelines for Creutzfeldt-Jakob and related agents , 1983, Journal of the Neurological Sciences.
[85] Blair T. Johnson,et al. Is Surgery a Risk Factor for Creutzfeldt-Jakob Disease? Outcome Variation by Control Choice and Exposure Assessments , 2008, Infection Control & Hospital Epidemiology.
[86] W. Rutala. APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc. , 1990, American journal of infection control.
[87] M. Bardsley. Surveillance for Creutzfeldt-Jakob disease--United States. , 1996, MMWR. Morbidity and mortality weekly report.
[88] A. Dickinson,et al. Resistance of scrapie agent to decontamination. , 1978, The New England journal of medicine.
[89] G. Mcdonnell,et al. Prion inactivation using a new gaseous hydrogen peroxide sterilisation process. , 2007, The Journal of hospital infection.
[90] W. Rutala,et al. Ineffectiveness of Hospital Disinfectants Against Bacteria: A Collaborative Study , 1987, Infection Control.
[91] Taylor Dm,et al. Resistance of scrapie agent to decontamination. , 1978 .
[92] P. Zampieri,et al. Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. , 2003, The New England journal of medicine.
[93] W. Rutala,et al. Effect of methodology, dilution, and exposure time on the tuberculocidal activity of glutaraldehyde-based disinfectants , 1990, Applied and environmental microbiology.
[94] J. Solassol,et al. Detection of prion after decontamination procedures: comparative study of standard Western blot, filter retention and scrapie-cell assay. , 2004, The Journal of hospital infection.
[95] D. Taylor,et al. Inactivation of the 22A strain of scrapie agent by autoclaving in sodium hydroxide. , 1997, Veterinary microbiology.
[96] S. Mok,et al. 3-Methyl-4-Chlorophenol for Prion Decontamination of Medical Devices , 2006, Infection Control & Hospital Epidemiology.
[97] Michael W. Miller,et al. Chronic Wasting Disease and Potential Transmission to Humans , 2004, Emerging infectious diseases.
[98] K. Uchida,et al. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent , 2005, Archives of Virology.
[99] P. Brown. Environmental Causes of Human Spongiform Encephalopathy , 1996 .
[100] A. Azarpazhooh,et al. Prion disease: the implications for dentistry. , 2008, Journal of endodontics.
[101] P. Brown,et al. Effect of chemicals, heat, and histopathologic processing on high-infectivity hamster-adapted scrapie virus. , 1982, The Journal of infectious diseases.
[102] D. Gajdusek,et al. DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY , 1977, The Lancet.
[103] M. De,et al. REUSABLE VERSUS DISPOSABLE INSTRUMENTS IN TONSILLECTOMY: A COMPARATIVE STUDY OF OUTCOMES , 2003, International journal of clinical practice.
[104] I. Mcconnell,et al. AUTOCLAVING DOES NOT DECONTAMINATE FORMOL-FIXED SCRAPIE TISSUES , 1988, The Lancet.
[105] D. Perrett,et al. Surface decontamination of surgical instruments: an ongoing dilemma. , 2006, The Journal of hospital infection.